Healthcare - Biotechnology - NASDAQ - US
$ 2.3
-6.5 %
$ 289 M
Market Cap
-4.11
P/E
BALANCE SHEET
306 M
ASSETS
40.2 M
LIABILITIES
265 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Nautilus Biotechnology, Inc.
| Current Assets | 177 M |
| Cash & Short-Term Investments | 173 M |
| Receivables | 0 |
| Other Current Assets | 3.42 M |
| Non-Current Assets | 129 M |
| Long-Term Investments | 90.6 M |
| PP&E | 36.9 M |
| Other Non-Current Assets | 1.18 M |
| Current Liabilities | 9.12 M |
| Accounts Payable | 1.64 M |
| Short-Term Debt | 7.08 M |
| Other Current Liabilities | 407 K |
| Non-Current Liabilities | 31.1 M |
| Long-Term Debt | 31.1 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 19.4 | 114.5 | 185.6 | 36.6 | 0.6 | 1.2 |
| Short Term Investments | 154.0 | 69.9 | 160.1 | 40.1 | 16.1 | 144 488.3 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 3.4 | 2.7 | 7.0 | 0.3 | 0.3 | (144 488.2) |
| Total Current Assets | 176.8 | 187.2 | 349.2 | 77.7 | 17.0 | 1.3 |
| PP&E | 36.9 | 32.6 | 31.9 | 6.2 | 1.1 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 90.6 | 129.2 | 16.4 | 0.6 | 147.8 | 144.5 |
| Other Long Term Assets | 1.2 | 1.1 | 1.0 | 0.5 | (147.4) | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 305.6 | 350.1 | 398.4 | 85.0 | 18.5 | 145.8 |
| LIABILITIES | ||||||
| Accounts Payable | 1.6 | 1.3 | 1.7 | 0.5 | 0.3 | 0 |
| Short Term Debt | 7.1 | 4.0 | 1.9 | 1.5 | 0 | 0 |
| Other Current Liabilities | 0.4 | 1.5 | 2.1 | 1.1 | 0.2 | 5 K |
| Total Current Liabilities | 9.1 | 6.8 | 5.8 | 3.0 | 0.5 | 5 K |
| Long Term Debt | 31.1 | 28.3 | 29.1 | 3.3 | 275.0 | 5.0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 108.4 | (275.0) | 0 |
| Total Liabilities | 40.2 | 35.1 | 34.9 | 114.7 | 0.5 | 140.8 |
| EQUITY | ||||||
| Common Stock | 13 K | 12 K | 12 K | 1 K | 1 K | 76 |
| Retained Earnings | (202.2) | (138.6) | (80.6) | (30.3) | (14.7) | 0.6 |
| Other Accumulative Comprehensive Income/Loss | (0.3) | (1.9) | (0.2) | 3 K | 7 K | 0 |
| Total Equity | 265.4 | 314.9 | 363.6 | (29.7) | 18.1 | 5.0 |
| Total Liabilities and Equity | 305.6 | 350.1 | 398.4 | 85.0 | 18.5 | 145.8 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 124.9 | 124.6 | 84.5 | 30.0 | 7.2 | 7.2 |